| lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AK123483 | Enterovirus 71 (GDFS-3 strain of EV 71) | 10^2 TCID50/mL ;
24 hr |
RD Human embryonal rhabdomyosarcoma cells | Microarray | 0.18392366 | Downregulation | p < 0.05 | GeneSpring GX v12.0 software package (Agilent Technologies) | Not provided | 2013 | 23220233 |
| MIR210HG | Human parainfluenza virus 3 (JS strain of HPIV3) | MOI = 2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells | RNA-Seq | 0.329470991 | Downregulation | 0.014670948 | student's t test | 2020 | 32416070 | |
| MIR210HG | Middle East Respiratory Syndrome Coronavirus (EMC_2012 strain of (MERS-CoV)) | MOI = 3 ;
24 hr |
MRC-5 Human fetal lung fibroblast cells | RNA-Seq | 0.594393399 | Downregulation | 5.00E-07 | student's t test | 2020 | 32416070 | |
| MIR210HG | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 0.2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells (ACE2+) | RNA-Seq | 0.442012784 | Downregulation | 0 | student's t test | 2020 | 32416070 | |
| MIR210HG | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells (ACE2+) | RNA-Seq | 1.863338556 | Upregulation | 0.005048805 | student's t test | 2020 | 32416070 | |
| MIR210HG | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
Calu-3 Human adenocarcinomic lung epithelialcells | RNA-Seq | 0.494499168 | Downregulation | 0.000136878 | student's t test | 2020 | 32416070 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose